VA And DoD Face Criticism From Rep. Blumenauer Over 'Misguided' Denial Of PTSD Treatment With Medical Cannabis
Portfolio Pulse from Joana Scopel
Rep. Earl Blumenauer (D-OR) has criticized the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) for their denial of medical marijuana as a treatment for PTSD in veterans. This comes after the VA and DoD released guidelines claiming the adverse effects of cannabis outweigh the benefits. Blumenauer's criticism coincides with the House approving an amendment to block the VA from enforcing policies that prevent doctors from recommending medical marijuana to veterans in legal states. Cannabis-related ETFs CNBS, YOLO, MJ, and THCX saw an increase in their share prices.
July 28, 2023 | 7:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amplify Seymour Cannabis ETF (CNBS) saw a 2.50% increase in its share price.
The criticism of the VA and DoD's stance on medical marijuana and the approval of an amendment blocking the VA from enforcing policies against it could lead to increased optimism in the cannabis sector, potentially driving up the share price of CNBS.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
ETFMG Alternative Harvest (MJ) saw a 3.29% increase in its share price.
The criticism of the VA and DoD's stance on medical marijuana and the approval of an amendment blocking the VA from enforcing policies against it could lead to increased optimism in the cannabis sector, potentially driving up the share price of MJ.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
AXS Cannabis ETF (THCX) saw a 2.22% increase in its share price.
The criticism of the VA and DoD's stance on medical marijuana and the approval of an amendment blocking the VA from enforcing policies against it could lead to increased optimism in the cannabis sector, potentially driving up the share price of THCX.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
AdvisorShares Pure Cannabis ETF (YOLO) saw a 2.13% increase in its share price.
The criticism of the VA and DoD's stance on medical marijuana and the approval of an amendment blocking the VA from enforcing policies against it could lead to increased optimism in the cannabis sector, potentially driving up the share price of YOLO.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50